Program & Schedule

Program and Schedule

For the full scientific program, please see below the schedule.
Please note the program and schedule are still being finalised.

Schedule (program at a glance) preview
Last updated: 19 June 2024


Preliminary schedule (program at a glance) download

Detailed Conference Program

15th Sep 2024 (Sunday)
16th Sep 2024 (Monday)
17th Sep 2024 (Tuesday)
18th Sep 2024 (Wednesday)
15:00

Participants Registration

Opening Ceremony

Chairs: Aljoša Bavec, Marko Goličnik, Stanko Gobec, Jure Stojan

Opening Session

Time Lecture
17:30 Distinguished Plenary Lecture cholinesterases
Hermona Soreq, Jerusalem (Israel)
A single nucleotide polymorphism in the human AChE gene alters miR-608 levels, anxiety and inflammatory status

Chairs: Stanko Gobec, Jure Stojan

 

Time Lecture
17:30 Distinguished Plenary Lecture paraoxonases
Carlo Cervellati, Ferrara (Italy)
PON1, as a common denominator of neurodegenerative and cardiovascular diseases: proactive player or static biomarker?

Chairs: Aljoša Bavec, Marko Goličnik

Carlo Cervellati
Hermona Soreq
19:00

Welcome Party

Session 1 – Structure and dynamics of cholinesterases, paraoxonases and phosphotriesterases

Chair and keynote lecturer: Joel L. Sussman, Rehovot (Israel)

Time Lecture
08:30 Keynote Lecture: Joel L. Sussman, Rehovot (Israel)
An Unusual α/β Hydrolase Fold Enzyme from an Antarctic Bacterium
09:00 Senior Lecture (20 min): Frank Raushel (USA)
Phosphotriesterase Catalyzed Synthesis of Chiral Precursors to Antiviral Prodrugs
09:20 Senior Lecture (20 min): Doriano Lamba (Italy)
Disentangling the Mechanism Underlying the Covalent MethaneSulfonyl Fluoride Acetylcholinesterase Adduct Formation and Evolvement: Structural and Mechanistic Insights into an Aged-like Inactive Complex Susceptible to Reactivation by a Combination of Nucleophiles.
09:40 Senior Lecture (20 min): Sofya Lushchekina (Israel)
Why is binding of a divalent metal cation to a structural motif containing four carboxylate residues not accompanied by a conformational change?
10:00 Junior Lecture (10 min flash presentation)
10:10 Junior Lecture (10 min flash presentation)
Joel L. Sussman
10:20

Coffee Break

Session 2 – Interactions of cholinesterases (AChE and BChE) with substrates, inhibitors and reactivators

Chair and keynote lecturer: Zrinka Kovarik, Zagreb (Croatia)

Time Lecture
10:45 Keynote Lecture: Zrinka Kovarik, Zagreb (Croatia)
Evaluating cholinesterase’s interactions with inhibitors and potent reactivators towards efficient treatment in organophosphate poisoning
11:15 Senior Lecture (20 min): Zoran Radić, La Jolla (USA)
Towards the fourth generation of effective uncharged bis-oxime reactivators of organophosphate-inhibited human AChE
11:35 Senior Lecture (20 min): José Dias, Brétigny sur Orge (France)
Development and therapeutic potential of uncharged cholinesterase reactivators
11:55 Senior Lecture (20 min): Jure Stojan, Ljubljana (Slovenia)
Direct Determination of the hydrolysis of poor substrates by human plasma
12:15 Junior Lecture (10 min flash presentation)
12:25 Junior Lecture (10 min flash presentation)
Zrinka Kovarik
12:35

Lunch Break

Session 3 – Post exposure organo phosphates strategies and toxicology

Chair and keynote lecturer: Ondrej Soukup, Hradec Králové (Czech Republic)

Time Lecture
14:00 Keynote Lecture: Ondrej Soukup, Hradec Králové (Czech Republic)
Novichok class of organophosphorus compounds and the efficacy of current countermeasures against A-234
14:30 Senior Lecture (20 min): Kamil Musilek (Czech Republic)
How to increase bioavailability and follow effect of charged oximes in the central nervous system?
14:50 Senior Lecture (20 min): Guilhem Calas (France)
Novel Strategies for Optimizing the Treatment of Organophosphate Poisoning in a Mouse Model
15:10 Senior Lecture (20 min): Fredrik Ekström (Sweeden)
Choline-O-acetyltransferase as a potential therapeutic target for nerve agent poisoning: Unveiling an ion sensitive regulatory mechanism
15:30 Junior Lecture (10 min flash presentation)
15:40 Junior Lecture (10 min flash presentation)
Ondrej Soukup
15:50

Coffee Break

Session 4 – Cholinesterase pharmacology, inhibitors and antidotes

Chair and keynote lecturer: Palmer Taylor, San Diego (USA)

Time Lecture
16:15 Keynote Lecture: Palmer Taylor, San Diego (USA)
Achieving a balance in Central and Peripheral Nervous Systems: Reactivation of Organophosphate Inhibition of Acetylcholinesterase
16:45 Senior Lecture: Yvonne Rosenberg, Rockville (USA)
Development of the post-exposure RS194B oxime against lethal sarin vapour and organophosphate insecticides in macaques
17:05 Senior Lecture (20 min): Anita Bosak, Zagreb (Croatia)
Detection of selective inhibitors of BChE in structurally and functionally different groups of molecules
17:25 Senior Lecture (20 min): Lukas Gorecki (Czech Republic)
Bifunctional compounds serving as versatile cholinesterase reactivators
17:45 Junior Lecture (10 min flash presentation)
17:55 Junior Lecture (10 min flash presentation)
Palmer Taylor
19:30

Dinner

Session 5 – Paraoxonase, butyrylcholinesterase and phosphotriesterase role in detoxication, biotechnology and diseases

Chair and keynote lecturer: Eugenio Vilanova-Gisbert, Elche (Spain)

Time Lecture
08:30 Keynote Lecture: Eugenio Vilanova-Gisbert, Elche (Spain)
The thin line between substrates or inhibitors: OP-enzymes interactions for biology, toxicity, diagnosis or applications
09:00 Senior Lecture (20 min): Boštjan Petrič (Slovenia)
New Insights into PON1 Reaction Mechanisms Based on Kinetic Analysis of Plasma Samples from a Patient Cohort
09:20 Senior Lecture (20 min): Antonio Monroy Noyola (Mexico)
Albumin-copper complex hydrolyses chiral organophosphate compounds as a true A-esterase
09:40 Senior Lecture (20 min): Jorge Estévez Domènech (Spain)
Special behavior of cholinesterase interactions among thiocholine and phenyl carboxyl ester as substrates and inhibitors: Implication for research applications.
10:00 Junior Lecture (10 min flash presentation)
10:10 Junior Lecture (10 min flash presentation)
Eugenio Vilanova-Gisbert
10:20

Coffee Break

Session 6 – Paraoxonases: function, diseases and therapeutic aspects

Chair and keynote lecturer: Judit Marsillach, Seattle (USA)

Time Lecture
10:45 Keynote Lecture: Judit Marsillach, Seattle (USA)
TBD
11:15 Senior Lecture (20 min): TBD
TBD
11:35 Senior Lecture (20 min): TBD
TBD
11:55 Senior Lecture (20 min): TBD
TBD
12:15 Junior Lecture (10 min flash presentation)
12:25 Junior Lecture (10 min flash presentation)
Judit Marsillach
12:35

Lunch Break

14:00

Trip to Bled

19:30

Gala Dinner

Session 7 – Translational research of inhibitors of cholinesterases and paraoxonases

Chair and keynote lecturer: Florian Nachon, Brétigny-sur-Orge (France)

Time Lecture
08:30 Keynote Lecture: Florian Nachon, Brétigny-sur-Orge (France)
Pharmaceutical development of butyrylcholinesterase
09:00 Senior Lecture (20 min): Brian Harvey, Potchefstroom (Republic of South Africa)
Selective butyrylcholinesterase inhibition induces antidepressant, pro-cognitive, and antianhedonic effects in a genetic animal model of depression: Role of acetylcholine, ghrelin, and dopamine
09:20 Senior Lecture (20 min): Diego Muñoz-Torrero, Barcelona (Spain)
Leveraging templating effects of acetylcholinesterase for the development of new anti-Alzheimer drug candidates with multiple mechanisms
09:40 Senior Lecture (20 min): Yoko Suzumoto
A novel identification of anti-hypertensive drug Spironolactone as an inhibitor of Paraoxonase 2 lactonase activity
10:00 Junior Lecture (10 min flash presentation)
10:10 Junior Lecture (10 min flash presentation)
Florian Nachon
10:20

Coffee Break

Session 8 – Multi-target-directed ligands in Alzheimer’s disease primarily targeting cholinesterases

Chair and keynote lecturer: Stanislav Gobec, Ljubljana (Slovenia)

Time Lecture
10:45 Keynote Lecture: Stanislav Gobec, Ljubljana (Slovenia)
Multi-target-directed ligands for potential symptomatic and disease-modifying treatment of Alzheimer’s disease
11:15 Senior Lecture (20 min): Christophe Rochais, Caen (France)
Advancing Neocopride: A Preclinical Candidate Multitarget Directed-Ligand (MTDL) for Neurodegenerative Disease Intervention
11:35 Senior Lecture (20 min): Jose Marco-Contelles, Madrid (Spain)
Cholinesterase-based Inhibitors as Multitarget Small Molecules for the therapy of Alzheimer’s Disease
11:55 Senior Lecture (20 min): Haopeng Sun, Nanjing (China)
Discovery of highly selective butyrylcholinesterase inhibitors for cognitive improvement
12:15 Junior Lecture (10 min flash presentation)
12:25 Junior Lecture (10 min flash presentation)
Stanislav Gobec
12:35

Lunch Break

Session 9 – Functions of cholinesterases in different tissues

Chair and keynote lecturer: Karl W.K. Tsim, Hong Kong (China)

Time Lecture
14:00 Keynote Lecture: Karl W.K. Tsim, Hong Kong (China)
Acetylcholinesterase Regulates Inflammatory Responses and Pigmentation in Skin Epidermis
14:30 Senior Lecture (20 min): Anna Hrabovska (Slovakia)
Characterizing Cardiac and Vascular Cholinesterases: From Molecular Insights to Therapeutic Prospects
14:50 Senior Lecture (20 min): Eric Krejci (France)
Mice with inactive cholinesterases: new tools to evaluate cholinergic and non-cholinergic functions of AChE
15:10 Senior Lecture (20 min): Heidi Q Xie (China, Hong Kong)
New perspectives on the effects of dioxin-like pollutants on acetylcholinesterase
15:30 Junior Lecture (10 min flash presentation)
15:40 Junior Lecture (10 min flash presentation)
Karl W.K. Tsim

Memorial

Chair: Eugenio Vilanova-Gisbert, Elche (Spain)

Eugenio Vilanova-Gisbert

Closing Lecture

Chair: Jure Stojan

Speaker: Israel Silman, Rehovot (Israel)
Structural Characterization of Orphan and Taxonomically Restricted Proteins

Israel Silman

Closing Remarks

Chairs: Aljoša Bavec, Marko Goličnik, Stanislav Gobec, Jure Stojan